Faster global financial news!
Hengrui Pharmaceuticals licenses oral weight-loss drug HRS-1596 to Novo Nordisk in a potential $2.6 billion deal.
China's Hengrui Pharmaceuticals announced it has licensed its self-developed oral GLP-1/GIP dual receptor agonist, HRS-1596, to Novo Nordisk, a global leader in weight-loss drugs, for all global markets outside Greater China. The deal includes an upfront payment of $300 million, plus up to $2.3 billion in development, regulatory, and commercialization milestone payments, potentially totaling up to $2.6 billion. Hengrui Pharmaceuticals' stock price rose over 3% after the news was announced. The agreement is expected to close in the fourth quarter of 2026, with Hengrui Pharmaceuticals retaining all rights to HRS-1596 in the Greater China region.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
WTI crude oil rose 3.23% from its previous close, currently trading at $89.034
-
2
Gold fell 2.66% from its previous close, currently trading at $3,881.04.
-
3
The yield on the 30-year US Treasury bond rose by about 8 basis points from the previous close, currently standing at 5.44%.
-
4
The 10-year US Treasury yield rose by about 8 basis points from the previous close, currently standing at 5.08%.
-
5
Citadel Securities has poached Matthew Zimmerman from Diameter Capital Partners to head investment-grade corporate bond trading.
-
6
Watami, the Japanese restaurant group, has its founder planning to take the company private through a management buyout (MBO)
-
7
Google DeepMind has launched Gemini 4 Hydrogen, with pricing set at $1.50 and $7.50 per million tokens for input and output, respectively.
-
8
What is RCN coin? Where to trade and buy RCN coin?
-
9
Microsoft services suffer widespread outage impacting thousands of users in North America; Amazon Web Services and Google users also report disruptions
-
10
What is HNW coin? Where can HNW coin be traded and bought?
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
